Circulating Dynamics of SARS-CoV-2 Variants between April 2021 and February 2022 in Turkey by Murat Sayan, Ayse Arikan, Murat Isbilen

Get full text

Prognostic value of midkine, syndecan-1, hyaluronan synthase-2, sestrin-1, laminin subunit alpha-4 and fibulin-3 for malignant pleural mesothelioma by Hakan Akgun, Selma Metintas, Guntulu Ak, Secil Demirkol Canlı, Murat Isbilen, Ali O. Gure, Muzaffer Metintas

Get full text

Six potential biomarkers for bladder cancer: key proteins in cell-cycle division and apoptosis pathways by Güldal Inal Gültekin, Özlem Timirci Kahraman, Murat Işbilen, Saliha Durmuş, Tunahan Çakir, İlhan Yaylim, Turgay Isbir

Get full text

A novel 20-gene prognostic score in pancreatic adenocarcinoma. by Seçil Demirkol Canlı, Ege Dedeoğlu, Muhammad Waqas Akbar, Barış Küçükkaraduman, Murat İşbilen, Özge Şükrüoğlu Erdoğan, Seda Kılıç Erciyas, Hülya Yazıcı, Burçak Vural, Ali Osmay Güre

Get full text

Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide. by Seyhan Turk, Can Turk, Muhammad Waqas Akbar, Baris Kucukkaraduman, Murat Isbilen, Secil Demirkol Canli, Umit Yavuz Malkan, Mufide Okay, Gulberk Ucar, Nilgun Sayinalp, Ibrahim Celalettin Haznedaroglu, Ali Osmay Gure

Get full text

RETRACTED ARTICLE: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT by Richard Hill, Patricia A. Madureira, Bibiana Ferreira, Inês Baptista, Susana Machado, Laura Colaço, Marta dos Santos, Ningshu Liu, Ana Dopazo, Selma Ugurel, Angyal Adrienn, Endre Kiss-Toth, Murat Isbilen, Ali O. Gure, Wolfgang Link

Get full text

Retraction Note: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT by Richard Hill, Patricia A. Madureira, Bibiana Ferreira, Inês Baptista, Susana Machado, Laura Colaҫo, Marta dos Santos, Ningshu Liu, Ana Dopazo, Selma Ugurel, Angyal Adrienn, Endre Kiss-Toth, Murat Isbilen, Ali O. Gure, Wolfgang Link

Get full text